Logo image of STEX

STREAMEX CORP (STEX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:STEX - US09073N3008 - Common Stock

3.03 USD
0 (0%)
Last: 12/31/2025, 8:00:01 PM
3.1052 USD
+0.08 (+2.48%)
After Hours: 12/31/2025, 8:00:01 PM
Fundamental Rating

0

Taking everything into account, STEX scores 0 out of 10 in our fundamental rating. STEX was compared to 186 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of STEX have multiple concerns. STEX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

STEX had negative earnings in the past year.
STEX had a negative operating cash flow in the past year.
STEX had negative earnings in each of the past 5 years.
In the past 5 years STEX always reported negative operating cash flow.
STEX Yearly Net Income VS EBIT VS OCF VS FCFSTEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

STEX has a Return On Assets of -30.57%. This is comparable to the rest of the industry: STEX outperforms 44.62% of its industry peers.
Industry RankSector Rank
ROA -30.57%
ROE N/A
ROIC N/A
ROA(3y)-1175.93%
ROA(5y)-781.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
STEX Yearly ROA, ROE, ROICSTEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for STEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STEX Yearly Profit, Operating, Gross MarginsSTEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50K -100K -150K

More info and screens

0

2. Health

2.1 Basic Checks

STEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
STEX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for STEX has been increased compared to 5 years ago.
STEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
STEX Yearly Shares OutstandingSTEX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
STEX Yearly Total Debt VS Total AssetsSTEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

STEX has an Altman-Z score of -2.98. This is a bad value and indicates that STEX is not financially healthy and even has some risk of bankruptcy.
STEX has a worse Altman-Z score (-2.98) than 63.44% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.98
ROIC/WACCN/A
WACC8.82%
STEX Yearly LT Debt VS Equity VS FCFSTEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 0.12 indicates that STEX may have some problems paying its short term obligations.
With a Current ratio value of 0.12, STEX is not doing good in the industry: 96.24% of the companies in the same industry are doing better.
STEX has a Quick Ratio of 0.12. This is a bad value and indicates that STEX is not financially healthy enough and could expect problems in meeting its short term obligations.
STEX's Quick ratio of 0.12 is on the low side compared to the rest of the industry. STEX is outperformed by 95.16% of its industry peers.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
STEX Yearly Current Assets VS Current LiabilitesSTEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 80.81% over the past year.
STEX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -63.89%.
STEX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -55.07% yearly.
EPS 1Y (TTM)80.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-289.42%
Revenue 1Y (TTM)-63.89%
Revenue growth 3Y-55.07%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 37.81% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y68.52%
EPS Next 2Y40.08%
EPS Next 3Y37.81%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
STEX Yearly Revenue VS EstimatesSTEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2026 2027 50M 100M
STEX Yearly EPS VS EstimatesSTEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 -5 -10 -15 -20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

STEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for STEX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STEX Price Earnings VS Forward Price EarningsSTEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STEX Per share dataSTEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

STEX's earnings are expected to grow with 37.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.08%
EPS Next 3Y37.81%

More info and screens

0

5. Dividend

5.1 Amount

STEX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

STREAMEX CORP

NASDAQ:STEX (12/31/2025, 8:00:01 PM)

After market: 3.1052 +0.08 (+2.48%)

3.03

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14 2025-11-14
Earnings (Next)04-13 2026-04-13/amc
Inst Owners29.39%
Inst Owner ChangeN/A
Ins Owners9.47%
Ins Owner Change35.35%
Market Cap450.29M
Revenue(TTM)13.00K
Net Income(TTM)-39.89M
Analysts82.86
Price Target12.24 (303.96%)
Short Float %7.82%
Short Ratio3.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)20%
PT rev (3m)N/A
EPS NQ rev (1m)-25%
EPS NQ rev (3m)-25%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 34637.56
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS-0.05
TBVpS-0.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.57%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1175.93%
ROA(5y)-781.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z -2.98
F-Score3
WACC8.82%
ROIC/WACCN/A
Cap/Depr(3y)36.29%
Cap/Depr(5y)95.03%
Cap/Sales(3y)364.03%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-289.42%
EPS Next Y68.52%
EPS Next 2Y40.08%
EPS Next 3Y37.81%
EPS Next 5YN/A
Revenue 1Y (TTM)-63.89%
Revenue growth 3Y-55.07%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-74.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y114.46%
EBIT Next 5YN/A
FCF growth 1Y57.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.3%
OCF growth 3YN/A
OCF growth 5YN/A

STREAMEX CORP / STEX FAQ

What is the ChartMill fundamental rating of STREAMEX CORP (STEX) stock?

ChartMill assigns a fundamental rating of 0 / 10 to STEX.


What is the valuation status for STEX stock?

ChartMill assigns a valuation rating of 1 / 10 to STREAMEX CORP (STEX). This can be considered as Overvalued.


Can you provide the profitability details for STREAMEX CORP?

STREAMEX CORP (STEX) has a profitability rating of 0 / 10.


Can you provide the financial health for STEX stock?

The financial health rating of STREAMEX CORP (STEX) is 0 / 10.